SCHEMBL12211642

SCHEMBL12211642

CC(O)c1noc(-c2ccc(Cl)cc2)c1C(O)c1cccnc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CYP19A1 P11511 1/20 0.42
CYP17A1 P05093 1/20 0.41
BRD4 O60885 1/20 0.39
GAA P10253 2/20 0.39
CYP3A4 P08684 5/20 0.37
PDE10A Q9Y233 1/20 0.37
CYP2C19 P33261 2/20 0.36
MAPT P10636 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
TSHR P16473 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP3A5 P20815 2/20 0.35
ALDH1A1 P00352 1/20 0.35
FFAR2 O15552 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2197826 0.93 SMN1; SMN2 (0.42) SMN1; SMN2LMNAL3MBTL1CYP19A1CYP17A1
SCHEMBL12211586 0.91 SMN1; SMN2 (0.41) SMN1; SMN2LMNAL3MBTL1CYP19A1CYP17A1
SCHEMBL2199854 0.84 CYP19A1 (0.44) SMN1; SMN2LMNAL3MBTL1CYP19A1CYP17A1
SCHEMBL2195573 0.82 BRD4 (0.42) SMN1; SMN2LMNAL3MBTL1CYP19A1CYP17A1
SCHEMBL2197190 0.81 SMN1; SMN2 (0.47) SMN1; SMN2LMNAL3MBTL1CYP19A1CYP17A1
SCHEMBL2197035 0.80 ATM (0.45) SMN1; SMN2LMNAL3MBTL1CYP19A1CYP17A1
SCHEMBL2198631 0.80 ATM (0.45) SMN1; SMN2LMNAL3MBTL1CYP19A1CYP17A1
SCHEMBL12211600 0.79 SMN1; SMN2 (0.39) SMN1; SMN2LMNAL3MBTL1CYP19A1CYP17A1
SCHEMBL2196294 0.79 L3MBTL1 (0.44) SMN1; SMN2LMNAL3MBTL1CYP19A1CYP17A1
SCHEMBL2198129 0.79 KCNA5 (0.47) SMN1; SMN2LMNAL3MBTL1CYP19A1CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110251066-A1 ISOXAZOLE DERIVATIVES FOR USE AS PLANT GROWTH REGULATORS SYNGENTA CROP PROTECTION LLC (US) 2011-10-13 US disclosed
US-20110251066-A1 ISOXAZOLE DERIVATIVES FOR USE AS PLANT GROWTH REGULATORS SYNGENTA CROP PROTECTION LLC (US) 2011-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110251066-A1 ISOXAZOLE DERIVATIVES FOR USE AS PLANT GROWTH REGULATORS CYP4Z1, CYP4X1, AGXT SMN1; SMN2 4879/4885LMNA 4574/4885L3MBTL1 4082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.